Literature DB >> 7158298

Neuropathology of chronic vitamine E deficiency in fatal familial intrahepatic cholestasis.

K Saito, T Yokoyama, M Okaniwa, S Kamoshita.   

Abstract

A progressive neuromuscular syndrome developed in a girl suffering from fatal familial intrahepatic cholestasis (Byler disease). The neuromuscular syndrome included muscular wasting of the legs, pes cavus, areflexia, decreased vibratory sensation, cerebellar symptoms, ophthalmoplegia, and visual disturbance with retinitis pigmentosa. The serum vitamin E level was extremely low. Postmortem neuropathologic study revealed the following lesions: (1) Systemic axonopathy involving the peripheral nerves and proximal axons of the dorsal root ganglia and posterior roots as well as the distal axons of the central nervous system (CNS) (2) Neuronal loss in the sensory and oculomotor nuclei of the brain stem, basal ganglia, Clarke's column, posterior horn, and dorsal root ganglia. (3) Neuronal lipofuscinosis. Axonopathy was severer in the more distal axonal segments, although the cuneate fasciculus was more affected than the gracile fasciculus. The severity of neuronal lipofuscinosis was not correlated with that of neuronal disintegration. The electron-dense bodies in the dystrophic swollen axons resembled lipofuscin granules. These neuropathologic lesions were considered to be the sequelae to chronic vitamin E deficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7158298     DOI: 10.1007/bf00690800

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE, MACULAR ATROPHY AND ACANTHOCYTOSIS (BASSEN-KORNZWEIG SYNDROME).

Authors:  L A SOBREVILLA; M L GOODMAN; C A KANE
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

2.  Effects of a prolonged vitamin E deficiency in the rat.

Authors:  L J Machlin; R Filipski; J Nelson; L R Horn; M Brin
Journal:  J Nutr       Date:  1977-07       Impact factor: 4.798

3.  Amyotrophic lateral sclerosis. Clinicopathological studies of a family.

Authors:  C W Metcalf; A Hirano
Journal:  Arch Neurol       Date:  1971-06

4.  Degeneration of fasciculus gracilis in cystic fibrosis.

Authors:  A Geller; F Gilles; H Shwachman
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

5.  Neuroaxonal dystrophy in man: character and natural history.

Authors:  K Jellinger; A Jirásek
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

6.  Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys.

Authors:  J S Nelson; C D Fitch; V W Fischer; G O Broun; A C Chou
Journal:  J Neuropathol Exp Neurol       Date:  1981-03       Impact factor: 3.685

7.  Neuroaxonal dystrophy in congenital biliary atresia.

Authors:  J H Sung; E M Stadlan
Journal:  J Neuropathol Exp Neurol       Date:  1966-07       Impact factor: 3.685

8.  A progressive neurologic syndrome in children with chronic liver disease.

Authors:  J L Rosenblum; J P Keating; A L Prensky; J S Nelson
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

9.  The neuropathy of abetalipoproteinemia.

Authors:  R G Miller; C J Davis; D R Illingworth; W Bradley
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

10.  Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides.

Authors:  E Azizi; J L Zaidman; J Eshchar; A Szeinberg
Journal:  Acta Paediatr Scand       Date:  1978-11
View more
  2 in total

1.  Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis.

Authors:  A Malandrini; G M Fabrizi; P Bartalucci; C Salvadori; G Berti; C Sabò; G C Guazzi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

2.  Ultrastructural pathology of dermal axons and Schwann cells in lysosomal diseases.

Authors:  S Walter; H H Goebel
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.